Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2017-01-05 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BREST (29200), Finistere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU CENTRE : revenue, balance sheet and financial ratios
PHARMACIE DU CENTRE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BREST (29200),
this company of category PME
shows in 2021 a revenue of 1.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU CENTRE (SIREN 824990659)
Indicator
2022
2021
Revenue
N/C
1 923 446 €
Net income
76 246 €
3 172 €
EBITDA
N/C
27 654 €
Net margin
N/C
0.2%
Revenue and income statement
In 2022, PHARMACIE DU CENTRE generates positive net income of 76 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2022: 3 k€ -> 76 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
76 246 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 718%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
718.119%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
9.531%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
Debt ratio
1613.393
718.119
Financial autonomy
4.674
9.531
Repayment capacity
98.701
None
Cash flow / Revenue
0.597%
None%
Sector positioning
Debt ratio
718.122022
2021
2022
Q1: 24.52
Med: 74.72
Q3: 182.51
Average
In 2022, the debt ratio of PHARMACIE DU CENTRE (718.12) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
9.53%2022
2021
2022
Q1: 28.54%
Med: 47.06%
Q3: 66.61%
Average
In 2022, the financial autonomy of PHARMACIE DU CENTRE (9.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
98.7 years2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Watch
In 2021, the repayment capacity of PHARMACIE DU CENTRE (98.70) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 322.98. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
322.98
Liquidity indicators evolution PHARMACIE DU CENTRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
Liquidity ratio
352.849
322.98
Interest coverage
27.728
None
Sector positioning
Liquidity ratio
322.982022
2021
2022
Q1: 145.17
Med: 199.48
Q3: 274.99
Excellent
In 2022, the liquidity ratio of PHARMACIE DU CENTRE (322.98) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
27.73x2021
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Excellent
In 2021, the interest coverage of PHARMACIE DU CENTRE (27.7x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2022)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2022)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2022)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2022)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DU CENTRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
Operating WCR
542 123 €
0 €
Inventory turnover (days)
103
0
Customer payment term (days)
2
0
Supplier payment term (days)
55
0
Positioning of PHARMACIE DU CENTRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE DU CENTRE is estimated at
897 149 €
(range 603 062€ - 1 345 557€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
603k€897k€1345k€
897 149 €Range: 603 062€ - 1 345 557€
NAF 5 année 2022
Valuation method used
Net Income Multiple
76 246 €
×
11.8x
=897 149 €
Range: 603 063€ - 1 345 557€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU CENTRE with other companies in the same sector:
Frequently asked questions about PHARMACIE DU CENTRE
What is the revenue of PHARMACIE DU CENTRE ?
The revenue of PHARMACIE DU CENTRE in 2021 is 1.9 M€.
Is PHARMACIE DU CENTRE profitable?
Yes, PHARMACIE DU CENTRE generated a net profit of 76 k€ in 2022.
Where is the headquarters of PHARMACIE DU CENTRE ?
The headquarters of PHARMACIE DU CENTRE is located in BREST (29200), in the department Finistere.
Where to find the tax return of PHARMACIE DU CENTRE ?
The tax return of PHARMACIE DU CENTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU CENTRE operate?
PHARMACIE DU CENTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart